{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:37:01Z","timestamp":1792089421334,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008799","name":"Gilead Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024580","name":"Orion Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003127","name":"Punainen Risti Veripalvelu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Childhood Disease Research Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","award":["4779"],"award-info":[{"award-number":["4779"]}],"id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201749","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:19:56Z","timestamp":1777994396000},"page":"201749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficient NK cell transduction with VSV-G-pseudotyped lentiviral vectors"],"prefix":"10.1016","volume":"34","author":[{"given":"Emmi","family":"J\u00e4rvel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Koski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tuhkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Elmadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Salokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erja","family":"Kerkel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekim","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Varjosalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Schenkwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Paavilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-4872","authenticated-orcid":false,"given":"Helka","family":"G\u00f6\u00f6s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201749_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201749_bib2","series-title":"Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2024","year":"2024"},{"key":"10.1016\/j.omta.2026.201749_bib3","series-title":"FDA Requires Boxed Warning for T Cell Malignancies Following Treatment with BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T Cell Immunotherapies","year":"2024"},{"key":"10.1016\/j.omta.2026.201749_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.omta.2026.201749_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","article-title":"Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy","volume":"14","author":"Gong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omta.2026.201749_bib6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omta.2026.201749_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/v12091016","article-title":"Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy","volume":"12","author":"Gutierrez-Guerrero","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201749_bib8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.gendis.2022.03.007","article-title":"Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?","volume":"10","author":"Deng","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.omta.2026.201749_bib9","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201749_bib10","article-title":"A distinct subset of highly proliferative and lentiviral vector (LV)-transducible NK cells define a readily engineered subset for adoptive cellular therapy","volume":"10","author":"Bari","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201749_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.omtm.2020.03.017","article-title":"Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor","volume":"17","author":"Gong","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201749_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1089\/hum.2012.080","article-title":"Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy","volume":"23","author":"Sutlu","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201749_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jcyt.2021.04.010","article-title":"Transient blockade of TBK1\/IKK epsilon allows efficient transduction of primary human NK cells with VSV-G-pseudotyped lentiviral vectors","volume":"23","author":"Chockley","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omta.2026.201749_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nm0896-876","article-title":"Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells","volume":"2","author":"Hanenberg","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201749_bib15","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/mtna.2013.17","article-title":"Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells","volume":"2","author":"Fenard","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2026.201749_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101473","article-title":"Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells","volume":"33","author":"Hayal","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201749_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.omtm.2021.01.008","article-title":"Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion","volume":"20","author":"Allan","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201749_bib18","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3389\/fimmu.2019.02873","article-title":"Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector","volume":"10","author":"Colamartino","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201749_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2023.114689","article-title":"Protocol for a high titer of BaEV-Rless pseudotyped lentiviral vector: Focus on syncytium formation and detachment","volume":"314","author":"Noguchi","year":"2023","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omta.2026.201749_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2022.1049580","article-title":"Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains","volume":"2","author":"Koski","year":"2022","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.omta.2026.201749_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2023.1070384","article-title":"Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors","volume":"3","author":"Jahan","year":"2023","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.omta.2026.201749_bib22","doi-asserted-by":"crossref","first-page":"26613","DOI":"10.1074\/jbc.M109.017566","article-title":"Structure of Signal-regulatory Protein \u03b1","volume":"284","author":"Hatherley","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201749_bib23","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1172\/JCI31661","article-title":"Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo","volume":"117","author":"Schwarzwaelder","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201749_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent anti-tumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omta.2026.201749_bib25","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3389\/fimmu.2019.03123","article-title":"High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia","volume":"10","author":"M\u00fcller","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201749_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41409-023-02180-4","article-title":"Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia","volume":"59","author":"Albinger","year":"2024","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201749_bib27","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201749_bib28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1182\/blood-2016-02-698027","article-title":"IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells","volume":"128","author":"Mao","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201749_bib29","doi-asserted-by":"crossref","first-page":"17702","DOI":"10.1074\/jbc.M802589200","article-title":"PDK1 Regulates Cell Proliferation and Cell Cycle Progression through Control of Cyclin D1 and p27Kip1 Expression","volume":"283","author":"Nakamura","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201749_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omta.2026.201749_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246228","article-title":"Greatwall-Endosulfine: A Molecular Switch that Regulates PP2A\/B55 Protein Phosphatase Activity in Dividing and Quiescent Cells","volume":"20","author":"Garc\u00eda-Blanco","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201749_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2021.02.013","article-title":"Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells","volume":"21","author":"Cordes","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201749_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201749_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0076-6879(02)46071-5","article-title":"[26] Generation of HIV-1 derived lentiviral vectors","volume":"346","author":"Follenzi","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omta.2026.201749_bib35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood-2014-02-558163","article-title":"Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs","volume":"124","author":"Girard-Gagnepain","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201749_bib36","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:31:49Z","timestamp":1788553909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000844"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201749","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.03.11.710988","asserted-by":"object"}]},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient NK cell transduction with VSV-G-pseudotyped lentiviral vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201749"}}